A federal appeals court in New Orleans is expected to weigh in on whether a commonly used pill, mifepristone, should remain widely available. Here is what’s at stake.
Author: Abbie VanSickle and Pam Belluck
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}